Last update 20 Sep 2025

GS3-007a

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
GS3 007A, GS3-007A, GS3007A
+ [1]
Target
GHSR
Action
agonists
Mechanism
GHSR agonists(Ghrelin/growth hormone secretagogue receptor agonists)
Therapeutic Areas
Nervous System DiseasesEndocrinology and Metabolic DiseaseOther Diseases+ [1]
Active Indication
Growth hormone deficiencyDyspepsia
Inactive Indication-
Originator Organization
Changchun Genescience Pharmaceuticals Co., Ltd.Changchun Genescience Pharmaceuticals Co., Ltd.
Active Organization
Changchun Genescience Pharmaceuticals Co., Ltd.Changchun Genescience Pharmaceuticals Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with GS3-007a
CTR20241396
/ Active, not recruitingPhase 1
GS3-007a干混悬剂在中国健康成年人中随机、双盲、安慰剂对照、单次和多次给药、剂量递增的I期临床研究
[Translation] A randomized, double-blind, placebo-controlled, single- and multiple-dose, dose-escalation phase I clinical study of GS3-007a dry suspension in healthy Chinese adults
NCT05921890
/ CompletedPhase 1
To Evaluate the Safety and Tolerability of GS3-007a Oral Solution in a Multi-dose, Randomized, Open, Single-center Study in Healthy Chinese Adult Subjects.
NCT05611281
/ CompletedPhase 1
Phase I Randomized, Double-blind, Placebo-controlled, Single Multiple Dosing, Dose Escalation, and Food Effect Study of GS3-007A Oral Liquid in Chinese Healthy Adults
100 Clinical Results associated with GS3-007a
Login to view more data
100 Translational Medicine associated with GS3-007a
Login to view more data
100 Patents (Medical) associated with GS3-007a
Login to view more data
100 Deals associated with GS3-007a
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Growth hormone deficiencyPhase 1
China
Changchun Genescience Pharmaceuticals Co., Ltd.Changchun Genescience Pharmaceuticals Co., Ltd.
21 Sep 2022
DyspepsiaPreclinical
China
Changchun Genescience Pharmaceuticals Co., Ltd.Changchun Genescience Pharmaceuticals Co., Ltd.
19 Jun 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free